NO20084591L - Fremgangsmater for a detektere og kontrollere fremstilling av mukoid Pseudomonas biofilm - Google Patents

Fremgangsmater for a detektere og kontrollere fremstilling av mukoid Pseudomonas biofilm

Info

Publication number
NO20084591L
NO20084591L NO20084591A NO20084591A NO20084591L NO 20084591 L NO20084591 L NO 20084591L NO 20084591 A NO20084591 A NO 20084591A NO 20084591 A NO20084591 A NO 20084591A NO 20084591 L NO20084591 L NO 20084591L
Authority
NO
Norway
Prior art keywords
detecting
controlling
methods
mucoidity
muce
Prior art date
Application number
NO20084591A
Other languages
English (en)
Other versions
NO342220B1 (no
Inventor
Hongwei D Yu
Dongru Qiu
Original Assignee
Marshall University Res Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marshall University Res Corp filed Critical Marshall University Res Corp
Publication of NO20084591L publication Critical patent/NO20084591L/no
Publication of NO342220B1 publication Critical patent/NO342220B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/21—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pseudomonadaceae (F)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Sammensetninger og metoder for å detektere og kontrollere omdannelsen til mukoiditet i Pseudomonas aeruginosa er omtalt. Foreliggende oppfinnelse tilveiebringer deteksjon av skiftet fra ikke-mukoid til mukoid tilstand av P. aeruginosa ved å måle mucE ekspresjon eller MucE proteinnivåer. Interaksjonen mellom MucE og AlgW kontrollerer skiftet til mukoiditet i villtype P. aeruginosa. Det er også omtalt et alginat biosyntese heterologt ekspresjonssystem for anvendelse i screening av kandidatsubstanser som inhiberer omdannelsen til mukoiditet.
NO20084591A 2006-03-31 2008-10-29 Fremgangsmåter for å detektere omdannelse til mukoiditet i en Pseudomonas aeruginosa bakterie NO342220B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78749706P 2006-03-31 2006-03-31
PCT/US2007/007964 WO2007123721A2 (en) 2006-03-31 2007-03-30 Methods of detecting and controlling mucoid pseudomonas biofilm production

Publications (2)

Publication Number Publication Date
NO20084591L true NO20084591L (no) 2008-12-29
NO342220B1 NO342220B1 (no) 2018-04-16

Family

ID=38625476

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084591A NO342220B1 (no) 2006-03-31 2008-10-29 Fremgangsmåter for å detektere omdannelse til mukoiditet i en Pseudomonas aeruginosa bakterie

Country Status (4)

Country Link
US (2) US7781166B2 (no)
EP (1) EP2008105B1 (no)
NO (1) NO342220B1 (no)
WO (1) WO2007123721A2 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5548121B2 (ja) 2007-05-14 2014-07-16 リサーチ ファウンデーション オブ ステイト ユニバーシティ オブ ニューヨーク バイオフィルム中の細菌細胞における生理学的分散応答の誘導
WO2009134368A2 (en) * 2008-04-29 2009-11-05 Marshall University Research Corporation Methods of producing bacterial alginates
WO2014193401A1 (en) 2013-05-31 2014-12-04 Empire Technology Development Llc Color change indicator of biofilm formation
WO2014193410A1 (en) * 2013-05-31 2014-12-04 Empire Technology Development Llc Method and device for detecting device colonization
DE202018006693U1 (de) * 2017-03-14 2022-03-08 Nanotag Biotechnologies Gmbh Target-Detektion mit einem monovalenten Antikörper
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
CN109355303B (zh) * 2018-11-14 2022-05-06 天津大学 抑制和/或敲除基因在提高单克隆抗体的表达量中的应用
CN111662950B (zh) * 2020-06-30 2023-03-28 陕西省微生物研究所 重组发光铜绿假单胞菌PAO1-lux在医用材料细菌粘附性检测中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716829A (en) * 1987-01-15 1998-02-10 Genetic Systems Corporation Diagnostic test for Pseudomonas aeruginosa infections
US6083691A (en) * 1993-02-12 2000-07-04 Board Of Regents, The University Of Texas System Detection of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients
US5591838A (en) * 1993-02-12 1997-01-07 Board Of Regents, The University Of Texas System Detection of conversion to mucoidy in pseudomonas aeruginosa infecting cystic fibrosis patients
US6905670B2 (en) * 1995-03-28 2005-06-14 The General Hospital Corporation Methods of screening compounds useful for prevention of infection or pathogenicity
CA2278314A1 (en) * 1997-01-16 1998-07-23 Scriptgen Pharmaceuticals, Inc. Nucleic acid encoding m. tuberculosis algu protein
US6153187A (en) * 1997-09-02 2000-11-28 Insight Strategy & Marketing Ltd. Use of glycosaminoglycans degrading enzymes for management of airway associated diseases
US6830745B1 (en) * 1997-10-16 2004-12-14 Pharmacal Biotechnologies, Llc Compositions for treating biofilm
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
US6610836B1 (en) * 1999-01-29 2003-08-26 Genome Therapeutics Corporation Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics
US7365185B2 (en) * 2000-07-19 2008-04-29 Monsanto Technology Llc Genomic plant sequences and uses thereof
US6777223B2 (en) * 2000-06-19 2004-08-17 Novozymes Biotech, Inc. Methods for eliminating the formation of biofilm
US7119172B2 (en) * 2001-05-21 2006-10-10 The Brigham And Women's Hospital, Inc. P. aeruginosa mucoid exopolysaccharide specific binding peptides
US6962813B2 (en) 2001-05-21 2005-11-08 The Brigham And Women's Hospital, Inc. P. aeruginosa mucoid exopolysaccharide specific binding peptides
AU2002340683C1 (en) * 2001-11-13 2009-11-12 Id Biomedical Corporation Of Quebec Polypeptides of pseudomonas aeruginosa
US20040266749A1 (en) * 2002-10-18 2004-12-30 Hassett Daniel J. Methods for cystic fibrosis disease assessment and methods for treating anaerobic P. aeruginosa biofilms in cystic fibrosis disease

Also Published As

Publication number Publication date
NO342220B1 (no) 2018-04-16
WO2007123721A2 (en) 2007-11-01
WO2007123721A3 (en) 2008-12-18
US7781166B2 (en) 2010-08-24
EP2008105A4 (en) 2009-12-02
US20110008786A1 (en) 2011-01-13
EP2008105A2 (en) 2008-12-31
US8399649B2 (en) 2013-03-19
EP2008105B1 (en) 2012-08-15
US20080085282A1 (en) 2008-04-10

Similar Documents

Publication Publication Date Title
NO20084591L (no) Fremgangsmater for a detektere og kontrollere fremstilling av mukoid Pseudomonas biofilm
DK1751302T3 (da) Analytsensorer og fremgangsmåder til fremstilling og anvendelse heraf
Yamada et al. Diverse functions of secreted frizzled-related proteins in the osteoblastogenesis of human multipotent mesenchymal stromal cells
Jun et al. N‐acetylcysteine stimulates osteoblastic differentiation of mouse calvarial cells
DE602006015793D1 (de) Proteolipidmembran und lipidmembranen-biosensor
NO20091660L (no) Autonom sjøbunns-seismikkanoderegistreringsanordning
WO2010132453A3 (en) Methods and compositions for analyte detection
NO20092505L (no) Fremgangsmate og anordning for automatisert, mekanisk-spesifikk-energi(MSE)-basert boring
WO2008021617A8 (en) Condensate glucose analyzer
BRPI0817571A2 (pt) planta para processar gás natural, aparelho método de processar gás associado com um ou mais poços de petróleo, e, sistema de controle para operar uma planta
DK1877390T3 (da) Benzisoxazol-piperazin-forbindelser og fremgangsmåder til anvendelse deraf
WO2005008252A3 (en) Methods and compositions for assaying homocysteine
DK2021794T3 (da) Anvendelse af protein S100A 12 som en markør for colorektal cancer
WO2009091815A3 (en) Methods for modulating de novo hepatic lipogenesis by modulating xbp-1 activity
NO20073680L (no) Fremgangsmate for a analysere data som har felles og saerskilte egenskaper
NO20093384L (no) Sykdomsmarkorer
NO20083986L (no) Anordning og framgangsmate for rengjoring av kabler
NO20075010L (no) Forbedret analyse av polymeriske anti-avleiringsmidler
RU2010152769A (ru) Способ определения эффективности биодеградации углеводородов нефти в нативных и загрязненных почвах
NO20080468L (no) Diazepinokinoliner, synteser av disse samt intermediater
BRPI0607222A2 (pt) estimativa de ruìdo em uma freqüência por amostragem de ruìdo em outras freqüências
WO2008079545A3 (en) Generation of plants with altered protein, fiber, or oil content
WO2007019526A3 (en) Compositions and methods for controlling glucose and lipid uptake from foods
GB2457832A (en) Novel toxicity assay based on human blastocyst-derived stem cells and progenitor cells
WO2008061153A3 (en) Generation of plants with altered protein, fiber, or oil content

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MARSHALL UNIVERSITY RESEARCH CORPORATION, US

MM1K Lapsed by not paying the annual fees